Determining how CD4+ T cells regulate adult liver stem cells during regeneration

The liver’s own repair system falters during chronic injury, and immune cells may hold the key to restarting it. When the liver is repeatedly damaged—by alcohol, fatty liver disease, or viral hepatitis—its usual method of healing, through hepatocyte division, fails. Instead, bile duct cells step in, transforming into new hepatocytes to patch the damage. But no one knows what controls this backup repair process. The researcher has observed immune cells clustering near bile ducts in diseased human livers, and early data suggest these cells can influence regeneration. This project will use human disease models to identify which immune cells are involved and how they signal to bile ducts. If the research succeeds, it could lead to drugs that coax the liver to heal itself without a transplant. Chronic liver disease is a growing global problem, and current treatments only slow its progression. Understanding this immune–bile duct conversation is fundamental science—it will not produce a therapy tomorrow. But similar discoveries about immune regulation have already reshaped cancer treatment and autoimmune disease management. A deeper grasp of how the body’s own cells and immune system cooperate during injury could eventually unlock regenerative therapies for millions.